The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial [PDF]
Megan Jones +17 more
openalex +1 more source
Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis [PDF]
Kiyoshi Ashida +7 more
openalex +1 more source
Potassium-competitive acid blockers and advances in the management of patients with acid-related diseases: a narrative review. [PDF]
Qiao X, Li P.
europepmc +1 more source
Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg [PDF]
Philip O. Katz, S. Xue, D. O. Castell
openalex +1 more source
Evaluation of the Safety and Efficacy of K-CAB (Tegoprazan) as Symptomatic Maintenance Therapy in Patients With NERD: A Multicenter, Randomized Double-Blinded Controlled Trial. [PDF]
Kwon YH +11 more
europepmc +1 more source
Clinical trial: intragastric acid control in patients who have Barrett’s oesophagus—comparison of once‐ and twice‐daily regimens of esomeprazole and lansoprazole [PDF]
Stuart J. Spechler +2 more
openalex +1 more source
Integrative pharmacovigilance and AI-based framework uncovers potential drug triggers in juvenile idiopathic arthritis. [PDF]
Luo Q +9 more
europepmc +1 more source

